(Q37061588)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18208788%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

review article

1 reference

title

The TGFBeta pathway as a therapeutic target in cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18208788%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18208788%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

author name string

Seoane J

series ordinal

1

1 reference

18 August 2017

publication date

1 January 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18208788%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Translational Oncology

1 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18208788%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18208788%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18208788%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

14-19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18208788%20AND%20SRC:MED&resulttype=core&format=json

Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism

1 January 2020

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12094-008-0148-2

Transgenic Mice Expressing a Dominant-Negative Mutant Type II Transforming Growth Factor-β Receptor Exhibit Impaired Mammary Development and Enhanced Mammary Tumor Formation

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12094-008-0148-2

Evaluation of anti-TGF-beta2 antibody as a new postoperative anti-scarring agent in glaucoma surgery.

21 January 2018

1 reference

12 December 2020

High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene

1 reference

12 December 2020

Mechanisms of TGF-beta signaling from cell membrane to the nucleus

1 reference

12 December 2020

SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7

1 reference

12 December 2020

Large- and small-molecule inhibitors of transforming growth factor-beta signaling.

1 reference

12 December 2020

Smad transcription factors

1 reference

12 December 2020

Transforming growth factor-beta and the immune response: implications for anticancer therapy

1 reference

12 December 2020

A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2

1 reference

12 December 2020

New insights into TGF-beta-Smad signalling

1 reference

12 December 2020

Specificity and versatility in tgf-beta signaling through Smads

1 reference

12 December 2020

Heterozygous mice for the transforming growth factor-beta type II receptor gene have increased susceptibility to hepatocellular carcinogenesis.

1 reference

12 December 2020

Hepatocellular expression of a dominant-negative mutant TGF-beta type II receptor accelerates chemically induced hepatocarcinogenesis

1 reference

12 December 2020

TGF-beta signaling: positive and negative effects on tumorigenesis

1 reference

12 December 2020

Role of Ras and Mapks in TGFbeta signaling

1 reference

12 December 2020

Targeting the TGF beta signaling network in human neoplasia

1 reference

12 December 2020

Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer

1 reference

12 December 2020

Intracerebral and intrathecal infusion of the TGF-beta 2-specific antisense phosphorothioate oligonucleotide AP 12009 in rabbits and primates: toxicology and safety

1 reference

12 December 2020

Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer

1 reference

12 December 2020

TGF beta inhibition for cancer therapy

1 reference

12 December 2020

Non-Smad TGF-beta signals

1 reference

12 December 2020

Inhibition of TGF-beta2 with AP 12009 in recurrent malignant gliomas: from preclinical to phase I/II studies

1 reference

12 December 2020

Smad-dependent and Smad-independent pathways in TGF-beta family signalling

1 reference

12 December 2020

Development of TGF-beta signalling inhibitors for cancer therapy

1 reference

12 December 2020

Regulation of the polarity protein Par6 by TGFbeta receptors controls epithelial cell plasticity

1 reference

12 December 2020

Transforming growth factor-beta-induced mobilization of actin cytoskeleton requires signaling by small GTPases Cdc42 and RhoA

1 reference

12 December 2020

Add-on anti-TGF-beta antibody to ACE inhibitor arrests progressive diabetic nephropathy in the rat.

1 reference

12 December 2020

Genetic models for transforming growth factor beta superfamily signaling in ovarian follicle development

1 reference

12 December 2020

SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo

1 reference

12 December 2020

Transforming growth factor beta-1 induces snail transcription factor in epithelial cell lines: mechanisms for epithelial mesenchymal transitions.

1 reference

12 December 2020

TGF-beta signaling in tumor suppression and cancer progression

1 reference

12 December 2020

Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death

1 reference

12 December 2020

Heterozygous TGFBR2 mutations in Marfan syndrome

1 reference

12 December 2020

Ras and TGF[beta] cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways

1 reference

12 December 2020

Making sense of latent TGFbeta activation

1 reference

12 December 2020

Alterations in components of the TGF-beta superfamily signaling pathways in human cancer

1 reference

12 December 2020

Escaping from the TGFbeta anti-proliferative control

1 reference

12 December 2020

Lifetime exposure to a soluble TGF-beta antagonist protects mice against metastasis without adverse side effects

1 reference

12 December 2020

Circulating transforming growth factor beta 1 as a predictor of liver metastasis after resection in colorectal cancer

1 reference

12 December 2020

Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells.

1 reference

12 December 2020

Stoichiometry of active smad-transcription factor complexes on DNA

1 reference

12 December 2020

Transforming growth factor-beta activation of phosphatidylinositol 3-kinase is independent of Smad2 and Smad3 and regulates fibroblast responses via p21-activated kinase-2

1 reference

12 December 2020

Targeted tumor therapy with the TGF-beta 2 antisense compound AP 12009.

1 reference

12 December 2020

Activated type I TGFbeta receptor kinase enhances the survival of mammary epithelial cells and accelerates tumor progression

1 reference

12 December 2020

10.1007/S12094-008-0148-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18208788%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference